These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 16522651)

  • 1. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.
    Deng CX
    Nucleic Acids Res; 2006; 34(5):1416-26. PubMed ID: 16522651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
    Deng CX
    Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.
    Xu X; Weaver Z; Linke SP; Li C; Gotay J; Wang XW; Harris CC; Ried T; Deng CX
    Mol Cell; 1999 Mar; 3(3):389-95. PubMed ID: 10198641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of BRCA1 and its interacting proteins.
    Deng CX; Brodie SG
    Bioessays; 2000 Aug; 22(8):728-37. PubMed ID: 10918303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1-associated tumorigenesis: what have we learned from knockout mice?
    Brodie SG; Deng CX
    Trends Genet; 2001 Oct; 17(10):S18-22. PubMed ID: 11585672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.
    Bouwman P; Aly A; Escandell JM; Pieterse M; Bartkova J; van der Gulden H; Hiddingh S; Thanasoula M; Kulkarni A; Yang Q; Haffty BG; Tommiska J; Blomqvist C; Drapkin R; Adams DJ; Nevanlinna H; Bartek J; Tarsounas M; Ganesan S; Jonkers J
    Nat Struct Mol Biol; 2010 Jun; 17(6):688-95. PubMed ID: 20453858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer susceptibility and the functions of BRCA1 and BRCA2.
    Venkitaraman AR
    Cell; 2002 Jan; 108(2):171-82. PubMed ID: 11832208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and prostate cancer.
    Rosen EM; Fan S; Goldberg ID
    Cancer Invest; 2001; 19(4):396-412. PubMed ID: 11405179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good timing in the cell cycle for precise DNA repair by BRCA1.
    Durant ST; Nickoloff JA
    Cell Cycle; 2005 Sep; 4(9):1216-22. PubMed ID: 16103751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BRCA1 in DNA damage response.
    Wu J; Lu LY; Yu X
    Protein Cell; 2010 Feb; 1(2):117-23. PubMed ID: 21203981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.
    O'Donovan PJ; Livingston DM
    Carcinogenesis; 2010 Jun; 31(6):961-7. PubMed ID: 20400477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
    Zhu Q; Pao GM; Huynh AM; Suh H; Tonnu N; Nederlof PM; Gage FH; Verma IM
    Nature; 2011 Sep; 477(7363):179-84. PubMed ID: 21901007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment.
    Shorrocks J; Tobi SE; Latham H; Peacock JH; Eeles R; Eccles D; McMillan TJ
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):470-8. PubMed ID: 14751517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1, a 'complex' protein involved in the maintenance of genomic stability.
    Savage KI; Harkin DP
    FEBS J; 2015 Feb; 282(4):630-46. PubMed ID: 25400280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors.
    Choi EK; Lim JA; Kim JK; Jang MS; Kim SE; Baek HJ; Park EJ; Kim TH; Deng CX; Wang RH; Kim SS
    Exp Mol Med; 2018 Oct; 50(10):1-16. PubMed ID: 30327455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells.
    Kim EH; Deng CX; Sporn MB; Liby KT
    Cancer Prev Res (Phila); 2011 Mar; 4(3):425-34. PubMed ID: 21372041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 regulates gene expression for orderly mitotic progression.
    Bae I; Rih JK; Kim HJ; Kang HJ; Haddad B; Kirilyuk A; Fan S; Avantaggiati ML; Rosen EM
    Cell Cycle; 2005 Nov; 4(11):1641-66. PubMed ID: 16258266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.